Novatio Ventures
Novatio Ventures accelerates the commercialization of high-potential, high-impact life science innovations. With a presence in Toronto, Boston, and Hong Kong, the firm focuses on global development opportunities, particularly from Canada, the U.S., China, and South Korea. Novatio targets early-stage innovations at the preclinical proof-of-concept stage, providing seed funding and strategic support to inventors and entrepreneurs. The firm leverages its extensive industry network to achieve early exits and generate attractive financial returns.
Novatio Ventures
First Canadian Place, 100 King Street West, Suite 5700, Toronto, Ontario M5X 1C7, Canada | One Broadway, 14th Floor, Cambridge, MA 02142, U.S.A.
What We Do
Novatio Ventures makes direct seed investments and advises on optimal fundraising strategies.
The firm advises on structuring new or spin-off entities and provides interim management to streamline operations and establish development strategies.
Novatio uses its global network to originate and execute licensing, partnership, and monetization transactions, including partner screening, targeting, deal structuring, valuation, and negotiations.
Portfolio
Secured seed funding to commercialize speech-based detection of cognitive impairments.
#Diagnostics
#Biotechnology
Received FDA 510(k) and Health Canada MDL clearance for its image guidance system for spine surgery.
#Medical Devices
#Biotechnology